All Activities
Choose from the criteria below to find an activity that fits you best.
Attention Pharmacists and Pharmacy Techs: Click to access CPE Monitor and CE information More Information ►
Featured Activity
Contemporary Evaluation and Management of Lung Cancer Targeted Therapies
Learn about treatment options, treatment failure, associated adverse effects and more.
Choose from the criteria below to find an activity that fits you best.
SHOW SEARCH
![]() |
A product of the Society of Infectious Diseases Pharmacists Education Center (SIDPEC) |
NOTE: If you attended the live CE activity titled "Strategies To Decrease Vancomycin-associated Nephrotoxicity - What Is Their Worth?" that was held on October 2, 2018 at the SIDP Annual Meeting in San Francisco, California, AND received CE credit (i.e. a pharmacist CE statement with ACPE Universal Activity Number 0221-9999-18-380-L01-P), you are NOT eligible to also receive CE credit for this home-study activity.
This activity will be divided into two different strategies to decrease Vancomycin-associated
nephrotoxicity. The first will examine the risk of concurrent piperacillin/tazobactam
and vancomycin in terms of nephrotoxicity. Faculty will discuss alternatives to reduce
nephrotoxicity, empiricism in gram negative coverage and strategies to mitigate nephrotoxicity
risk. The second strategy will focus on dosing Vancomycin using troughs versus AUC(area
under the curve) and will examine benefits and downsides of each as well as the available
Bayesian software.
This is a featured CE activity on the Society of Infectious Diseases Pharmacists Education
Center (SIDPEC) website. SIDPEC is the educational hub of the Society of Infectious
Diseases Pharmacists (SIDP). The SIDPEC portal provides educational activities on
infectious disease pharmacotherapy for clinical pharmacists, health‐systems
pharmacists, community pharmacists, and other allied‐health disciplines.
The target audience for this activity is pharmacists. At the completion of this activity, the participant will be able to:
Kari A. Mergenhagen PharmD, BCPS AQ-ID
Infectious Diseases Pharmacist
VA Western New York Healthcare System
Emi Minejima, PharmD
Assistant Professor of Clinical Pharmacy
USC School of Pharmacy
Release Date: 10-2-2018
Expiration Date: 10-2-2021
This activity is jointly provided by ProCE, Inc. and the Society
of Infectious Diseases Pharmacists. ProCE, Inc. is accredited by the Accreditation
Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE
Universal Activity Number 0221-9999-18-380-H01-P has been assigned to this home-study
knowledge-based activity (initial release date 10-2-2018). This activity is approved
for 0.75 contact hours (0.075 CEU) in states that recognize ACPE providers. The
activity is provided at no cost to participants. Participants must complete the online
post-test and activity evaluation to receive pharmacy CE credit. No partial credit
will be given. Statements of completion will be issued online at www.ProCE.com, and
proof of completion will be posted in NABP CPE Monitor profiles.
It is the policy of ProCE, Inc. to ensure balance, independence, objectivity and
scientific rigor in all of its continuing education activities. Faculty must disclose
to participants any significant financial interest or affiliation with companies that
manufacture or market products discussed in this activity. Dr. Mergenhagen and Dr.
Minejima have no relevant commercial or financial relationships to disclose.
Please note: The information and views presented in this activity are those of the
faculty through clinical practice and knowledge of the professional literature. Portions
of this activity may include the use of drugs and/or devices for unlabeled indications,
which should be considered experimental. Participants are advised to consult manufacturer
product information and the professional literature, and use professional judgment
in applying the presented information in patient-care activities.
This activity is partially supported by an educational grant from Accelerate Diagnostics, Inc.
The material presented in this CE activity does not reflect the views of ProCE, LLC or the commercial sponsor. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.